U.K. Cancer Photodynamic Therapy Market to 2032
Overview
The U.K. Cancer Photodynamic Therapy Market is expected to reach a 186.56 USD Million by 2032 and is projected to grow at a CAGR of 7.01% from 2025 to 2032.
U.K. Cancer Photodynamic Therapy Market 2018-2032 USD Million
U.K. Cancer Photodynamic Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 109.54 USD Million
- Projected Market Size (2032): 186.56 USD Million
- CAGR (2025-2032): 7.01%
Key Findings of U.K. Cancer Photodynamic Therapy Market
- The U.K. Cancer Photodynamic Therapy Market was valued at 109.54 USD Million in 2024.
- The U.K. Cancer Photodynamic Therapy Market is likely to grow at a CAGR of 7.01% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Early-Stage Cancer in Disease Stage Segment accounted for the largest share of the market with a revenue of 89.00 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 7.78% during the forecast period from 2024 to 2032.
U.K. Cancer Photodynamic Therapy Market Scope
- Others
- Online
- Third Party Distributors
- Direct Tender
- Others
- Academic & Research Institutes
- Ambulatory Surgical Centers (ASCS)
- Dermatology & Skin-cancer clinics
- Hospitals
- Pediatric
- Adults
- Geriatric
- Late-Stage Cancer
- Early-Stage Cancer
- Others
- Interstitial (Internal) Delivery
- Intracavitary (Endoscopic) Delivery
- External Beam
- Others
- Palliation therapy
- Adjunctive therapy
- Standalone therapy
- Prostate
- Cervical
- Bladder
- Lung
- Esophagal
- Head & Neck
- Skin & Cutaneous Oncology
- Photodynamic Therapy Devices
- Photosensitizer Drugs
U.K. Cancer Photodynamic Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 109.54 USD Million |
| Market Value in 2032 | 186.56 USD Million |
| CAGR (2025-2032) | 7.01% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Patient Demographics,Disease Stage,Procedure Technique,Therapy Modality,Cancer Indication,Product Type |
Regional Insights:
-
Leading Market (2024-2032): U.K., leading in terms of revenue 109.54 USD Million in 2024
- Key Country: U.K., leading in terms of revenue with value of 109.54 USD Million in 2024.
Segments and Scope
-
U.K. Cancer Photodynamic Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a revenue of 54.91 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 7.31 % in forecast period 2025-2032.
-
U.K. Cancer Photodynamic Therapy Market to 2032, By End User
- Hospitals is the largest segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a revenue of 44.27 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 7.78 % in forecast period 2025-2032.
-
U.K. Cancer Photodynamic Therapy Market to 2032, By Patient Demographics
- Geriatric is the largest segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a revenue of 72.86 USD Million in the year 2024.
- Geriatric is the Fastest growing segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 7.24 % in forecast period 2025-2032.
-
U.K. Cancer Photodynamic Therapy Market to 2032, By Disease Stage
- Early-Stage Cancer is the largest segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a revenue of 89.00 USD Million in the year 2024.
- Early-Stage Cancer is the Fastest growing segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 7.09 % in forecast period 2025-2032.
-
U.K. Cancer Photodynamic Therapy Market to 2032, By Procedure Technique
- External Beam is the largest segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a revenue of 75.22 USD Million in the year 2024.
- Intracavitary (Endoscopic) Delivery is the Fastest growing segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 6.96 % in forecast period 2025-2032.
-
U.K. Cancer Photodynamic Therapy Market to 2032, By Therapy Modality
- Standalone therapy is the largest segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a revenue of 44.25 USD Million in the year 2024.
- Standalone therapy is the Fastest growing segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 7.53 % in forecast period 2025-2032.
-
U.K. Cancer Photodynamic Therapy Market to 2032, By Cancer Indication
- Skin & Cutaneous Oncology is the largest segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a revenue of 56.32 USD Million in the year 2024.
- Skin & Cutaneous Oncology is the Fastest growing segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 7.59 % in forecast period 2025-2032.
-
U.K. Cancer Photodynamic Therapy Market to 2032, By Product Type
- Photosensitizer Drugs is the largest segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a revenue of 81.87 USD Million in the year 2024.
- Photosensitizer Drugs is the Fastest growing segment in U.K. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 7.14 % in forecast period 2025-2032.
U.K. Cancer Photodynamic Therapy Market Company Share Analysis
| Company Name |
|
||
| Novartis AG | |||
| Bausch Health Companies Inc. | |||
| Advanz Pharma | |||
| Galderma | |||
| Photocure | |||
U.K. Cancer Photodynamic Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
U.K. Cancer Photodynamic Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
U.K. Cancer Photodynamic Therapy Market Scope
- Others
- Online
- Third Party Distributors
- Direct Tender
- Others
- Academic & Research Institutes
- Ambulatory Surgical Centers (ASCS)
- Dermatology & Skin-cancer clinics
- Hospitals
- Pediatric
- Adults
- Geriatric
- Late-Stage Cancer
- Early-Stage Cancer
- Others
- Interstitial (Internal) Delivery
- Intracavitary (Endoscopic) Delivery
- External Beam
- Others
- Palliation therapy
- Adjunctive therapy
- Standalone therapy
- Prostate
- Cervical
- Bladder
- Lung
- Esophagal
- Head & Neck
- Skin & Cutaneous Oncology
- Photodynamic Therapy Devices
- Photosensitizer Drugs
Frequently Asked Questions
U.K. Cancer Photodynamic Therapy Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.